Two of our publication leads at Spirit attended the recent ISMPP EU meeting in London last month. Dawn Lobban (CMPP) moderated an interesting panel session on GPP3 and facilitated a roundtable discussion with key experts on patient lay summaries, while Fiona Bolland (CMPP) presented a poster on ‘The impact of data extrapolation on publication plans for biosimilars’.
Dawn and Fiona really enjoyed the discussions at ISMPP and have captured some of the key insights in a newsletter. We hope you find this summary useful – indeed if any of the ‘hot topics’ are of particular interest, the team would be delighted to discuss these with you further and provide more detail. As publications are a core part of our business, we have a genuine interest in how the field is evolving and how we can continue to provide an optimal service to our clients and authors.